Mazdutide and Tirzepatide Interaction

Avoid
Researched 95% confidence

Mazdutide and Tirzepatide have a potentially harmful interaction with 95% confidence. Both target GLP-1 receptor; additive effects on GI symptoms and hypoglycemia risk. Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

Mazdutide

Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes

Dual agonist activation: GLP-1 stimulates insulin, suppresses glucagon, slows gastric emptying; Glucagon increases energy expenditure and thermogenesis while GLP-1 counteracts glucose-raising effects..

Half-life: 6-8 days Typical dose: Start 1.5-3mg weekly, titrate up to 6-9mg based on response weight loss, metabolic
insulin disruptingteratogenic
View full profile

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes

Dual agonist targeting both GIP and GLP-1 receptors, producing glucose-dependent insulin stimulation, delayed gastric emptying, glucagon suppression, and central satiety signaling via hypothalamic pathways..

Half-life: ~5 days (120 hours) Typical dose: 2.5mg starting, titrate up to 5-15mg weekly weight loss, metabolic
glp1 receptor teratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Mazdutide, Tirzepatide). Monitor accordingly.

Frequently Asked Questions

Can I take Mazdutide with Tirzepatide?

Combining Mazdutide with Tirzepatide is not recommended. Both target GLP-1 receptor; additive effects on GI symptoms and hypoglycemia risk.

Is Mazdutide and Tirzepatide safe together?

This combination carries significant risk. Both target GLP-1 receptor; additive effects on GI symptoms and hypoglycemia risk. Consult a healthcare professional before combining.

What are the interactions between Mazdutide and Tirzepatide?

Both target GLP-1 receptor; additive effects on GI symptoms and hypoglycemia risk. This assessment has 95% confidence and is based on documented research data.

How should I time Mazdutide and Tirzepatide?

Mazdutide has a half-life of 6-8 days and Tirzepatide has a half-life of ~5 days (120 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Mazdutide vs Tirzepatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.